Skip to main content
Equibles
CGC logo

CGC · Canopy Growth Corp · Metrics

Track CGC — free

Use CGC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CGC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.72 +0.00 (+0.61%)
Rebalance outlook locked
Market Cap
$302.77M
Shares
423.04M
Volume · Oct 20 1.17M Avg daily vol (3M) 2.92M

CGC metrics

75 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.72
Market cap
$302.77M

Price action

20 metrics
Price change (1W)
-5.5%
Price change (30D)
-22.5%
Price change (3M)
-23.4%
Price change (6M)
-40.4%
Price change (YTD)
-37.2%
Price change (1Y)
-45.4%
Trailing year
Price change (5Y)
—
52-week high
$1.92
52-week low
$0.71
Change from 52-week high
-62.7%
Change from 52-week low
+0.4%
Annualized volatility
81.4%
Annualized volatility (3M)
40.1%
Beta
1.3
RSI (14D)
23.3
Price vs SMA 50
-23.1%
Price vs SMA 200
-30.1%
Avg volume (3M)
2.92M
Relative volume
0.6
Average dollar volume
$2.75M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
423.04M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1.1×
reciprocal yield 90.5%
EV / EBITDA
—
EV / EBIT
—
P / sales
1.4×
reciprocal yield 70.2%
P / book
0.6
reciprocal yield 160.1%
FCF yield
-19.9%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-55.6%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-07

Profitability

9 metrics
Gross margin
25.2%
Operating margin
-54.9%
Trailing 12 months
Net margin
-79.2%
Gross profit (TTM)
$73.87M
Operating profit (TTM)
−$161.15M
Net income (TTM)
−$168.38M
Trailing 12 months
Diluted EPS (TTM)
$-0.49
FCF margin
-28.3%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$1.65

Growth

11 metrics
Revenue growth YoY
+12.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$212.54M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+124.2%
Year over year · more shares
Revenue CAGR (3Y)
-5.1%
Revenue CAGR (5Y)
-12.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-33.8%
Return on assets
-21.1%
Debt / equity
0.3
Current ratio
3.0
EBITDA (TTM)
—
Free cash flow (TTM)
−$60.25M
Quick ratio
2.4
Interest coverage
-3.9
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$67.88M
Latest balance sheet
Cash & equivalents
$236.98M
Total assets
$777.13M
Total debt
$169.10M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$56.81M
Capital expenditures (TTM)
$3.45M
R&D (TTM)
—
SG&A (TTM)
$117.33M
Stock compensation (TTM)
$4.14M
R&D / revenue
—
Stock compensation / revenue
1.9%

Ownership (13F)

9 metrics
13F filers
217
13F filer change QoQ
-9
Institutional ownership
9.0%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
1.6%
Private-fund adviser ownership
0.5%
Active holders' share change QoQ
+0.0%
Holder tenure
14.8
Price vs estimated holder cost
-45.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
2.2%

Short interest

3 metrics
Short interest
6.4%
Latest settlement · 13.0 days to cover
Days to cover
13.0d
Short-squeeze score
64 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$87,156
Insider-sentiment score
32 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1737927 CUSIP 138035704 13F (30d) 28 filings 23 filers Visit website Investor relations